Kashyap Patel

Kashyap Patel

Company: Community Oncology

Job title: President

Seminars:

Translational Case Study: Translational Development of IACS-6274, a Potent and Selective Glutaminase (GLS1) Inhibitor in Phase 1 Trials for Molecularly-Defined Subsets of Patients with Advanced Solid Tumors 8:00 am

IACS-6274 is a potent, selective inhibitor of GLS1, that has excellent physicochemical properties and demonstrates selective anti-tumor effects in subsets of ovarian cancer and non-small cell lung cancers Through a comprehensive translational effort, we uncovered a reliance on GLS1 driven by unique cellular dependencies and identified clinically actionable patient stratification biomarkers An integrated approach that…Read more

day: Day One

Equity & Diversity in Precision Medicine: Better Drugs for Disease Heterogeneity in Diverse Populations 9:30 am

Highlighting societal healthcare disparities and the precision medicine opportunity to better treat diverse populations Accessibility to precision medicines Connecting the community, from regulatory, diagnostic and biopharma standpoint, on improving access to better, more varied, precision medicineRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.